Five years after the start of the COVID-19 pandemic, China is facing another public health challenge: the rapid outbreak of human metapneumovirus (HMPV). Reports and social media posts suggest the virus is spreading rapidly, with some alleging that hospitals and crematoriums are overwhelmed. Videos circulating online depict overcrowded hospitals, showing the concurrent spread of multiple viruses, including influenza A, mycoplasma pneumoniae and COVID-19.

What is HMPV?

Unverified claims suggest that China has declared a state of emergency due to the outbreak, although officials have not confirmed this. hMPV, a virus known to cause flu-like symptoms, can mimic COVID-19 in its presentation, increasing the need for health officials to monitor the situation closely. A social media post by the handle “SARS-CoV-2 (Covid-19)” raised concerns, saying:

“China is experiencing a surge in multiple viruses, including influenza A, HMPV, mycoplasma pneumonia and COVID-19, placing enormous pressure on hospitals and crematoriums. Children’s hospitals are particularly vulnerable to rising pneumonia and ‘white lung’ Are stressed over the affairs of.

Increasing cases of respiratory diseases

This outbreak coincides with an expected seasonal increase in respiratory illnesses. China’s disease control authority is operating a surveillance system to track pneumonia of unknown origin. The National Centers for Disease Control and Prevention Administration has announced measures to increase preparedness to deal with emerging pathogens, addressing gaps seen during the early stages of the COVID-19 crisis, according to a Reuters report. Are.

Kan Biao, an administration official, said respiratory infections are expected to increase during winter and spring. Data from 16–22 December indicate an increase in cases of acute respiratory diseases, particularly among persons under 14 years of age in the northern provinces. Pathogens identified include rhinovirus and HMPV, the latter of which has seen a significant increase.

The Chinese government is setting up protocols for laboratories and disease control agencies to more efficiently report, verify and manage cases. These measures are intended to ensure early detection of potential outbreaks and a prompt response, in contrast to the delayed actions taken in the early days of the COVID-19 pandemic.

Experts are cautioning against indiscriminate use of antiviral drugs to combat HMPV. A respiratory specialist at a Shanghai hospital stressed in an interview with the National Business Daily that there is no vaccine for HMPV, and its symptoms are very similar to those of the common cold. The expert warned that abuse of the drug could increase health risks.

overwhelmed health facilities

The pressure on health facilities is evident, especially in pediatric hospitals. Increasing cases of pneumonia, including severe manifestations known as “white lung” cases, are causing significant concern. Videos and reports on social media show long queues at hospitals, with parents struggling to get care for their children.

Although the exact scale of the outbreak remains unclear, the presence of multiple circulating viruses has complicated the situation. Influenza A, Mycoplasma pneumoniae and HMPV collectively contribute to the burden on the health care system, leading to a shortage of resources during the peak winter season.

China’s proactive steps in implementing a respiratory disease surveillance system signal a significant shift in its approach to public health crises. While health officials work to prevent the spread of hMPV and other respiratory pathogens, the public is urged to take precautions and follow hygiene practices to limit transmission of the virus. With the existing challenges posed by winter respiratory illnesses, the focus is on protecting public health and preventing the crisis from escalating.

Get the latest news live on Times Now with breaking news and top headlines from around the world.